Severe Hypertriglyceridemia Associated With Acute Pancreatitis in a Patient on Risankizumab
Related Experiment Video
Updated: Oct 31, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Soukaina El Yazal1, Aastha Chokshi2, Dania Hudhud2
1Department of Internal Medicine, Capital Health Regional Medical Center, Trenton, NJ.
Abstract:
Hypertriglyceridemia is a frequent condition, and it has many causes including obesity, hypothyroidism, and some medication. Exploring the cause is mandatory to avoid complications such as acute pancreatitis. We reported a case of hypertriglyceridemia-induced pancreatitis, started after starting risankizumab for Crohn's disease. This case describes the possible association between the increase of triglyceride level and the use of risankizumab, which was revealed by hypertriglyceridemia-induced acute pancreatitis.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
